Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Gland Pharma Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 1 October 2026, 8:31 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price2,874₹ per share
Reported P/E33.5Times
Book value per share656₹ per share
Reported ROCE17.4 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 1 October 2026, 8:31 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap47,356 Cr.
Current Price2,874
High / Low3,042/1,574
Stock P/E33.5
Book Value656
Dividend Yield0.70 %
ROCE17.4 %
ROE12.8 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Gland Pharma Ltd 47,356 Cr. 2,874 3,042/1,57433.5 6560.70 %17.4 %12.8 % 1.00
Glaxosmithkline Pharmaceuticals Ltd 46,973 Cr. 2,771 3,121/2,08844.6 1342.06 %61.4 %45.6 % 10.0
Ipca Laboratories Ltd 49,292 Cr. 1,943 2,039/1,25235.9 3180.31 %17.0 %15.7 % 1.00
Ajanta Pharma Ltd 44,789 Cr. 3,581 3,797/2,37939.5 3620.89 %34.5 %27.1 % 2.00
J B Chemicals & Pharmaceuticals Ltd 38,677 Cr. 2,409 2,526/1,60353.8 2590.91 %25.4 %18.9 % 1.00
Industry Average17,560.90 Cr1,250.1654.88211.240.39%26.16%16.59%6.06

All Competitor Stocks of Gland Pharma Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 8841,0111,0981,1751,0121,0631,0111,0301,0391,0741,1781,2621,287
Expenses 625664728742718699620636680699756754813
Operating Profit 259347369433294364391394359375422508474
OPM % 29%34%34%37%29%34%39%38%35%35%36%40%37%
Other Income 354143474858654455833610659
Interest 21151018374061
Depreciation 39404043414244434445454344
Profit before tax 254347372433300380394391362409412565488
Tax % 26%26%26%26%26%26%25%26%26%26%25%26%25%
Net Profit 188258277321223282295290269302308420364
EPS in Rs 11.3915.6416.8119.5113.5317.1017.9117.6016.3418.3318.6925.5222.09

Last Updated: September 29, 2026, 9:39 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 1, 2026, 8:31 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 9919941,3481,4791,6202,0442,6333,4634,4013,6174,1674,1164,5524,800
Expenses 6306788458541,0851,3381,6782,1612,8902,5982,7582,6742,8893,022
Operating Profit 3613165026255357069551,3021,5111,0191,4101,4431,6631,778
OPM % 36%32%37%42%33%35%36%38%34%28%34%35%37%37%
Other Income 93037344966139135224184166215279284
Interest 13171664473578231811
Depreciation 2857637478829599110147162169176176
Profit before tax 3272724595785026869931,3351,6191,0481,4051,4661,7481,874
Tax % 32%23%32%28%36%34%22%25%25%26%26%26%26%
Net Profit 2242093144143214527739971,2127761,0431,0901,3001,395
EPS in Rs 190.40133.53202.40267.01207.24291.6549.8860.9473.7847.1163.3466.1478.8884.63
Dividend Payout % 0%-0%-0%-0%-0%-0%-0%-0%-0%-0%32%27%25%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)-6.70%50.24%31.85%-22.46%40.81%71.02%28.98%21.56%-35.97%34.41%4.51%19.27%
Change in YoY Net Profit Growth (%)0.00%56.94%-18.39%-54.31%63.27%30.21%-42.04%-7.41%-57.54%70.38%-29.90%14.76%

Gland Pharma Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:15%
5 Years:9%
3 Years:-2%
TTM:-4%
Compounded Profit Growth
10 Years:18%
5 Years:7%
3 Years:-3%
TTM:5%
Stock Price CAGR
10 Years:Not available
5 Years:Not available
3 Years:-8%
1 Year:0%
Return on Equity
10 Years:15%
5 Years:14%
3 Years:12%
Last Year:12%

Last Updated: September 5, 2025, 4:45 am

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: October 1, 2026, 8:31 pm

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 161516161616161616161616
Reserves 1,3791,6622,0742,3952,8473,6315,8877,1427,9378,9799,73910,794
Borrowings 1661176655554453
Other Liabilities 197292378512655435588671815542661794
Total Liabilities 1,7582,0862,4742,9283,5234,0866,4967,8348,7739,54110,42211,607
Fixed Assets 6497888728439299689541,5021,5711,6941,7451,688
CWIP 19220216119912318833819117712042138
Investments 00-0-0-0-0116382,3862,7903,293
Other Assets 9171,0961,4411,8872,4712,9295,2035,9787,0175,3425,8456,489
Total Assets 1,7582,0862,4742,9283,5234,0866,4967,8348,7739,54110,42211,607
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 2204762021857016057913681,1361,0741,135
Cash from Investing Activity + -12-100-359-319-761-1,521-1,0071,211-2,9181,582-74
Cash from Financing Activity + -93-116-4-3-71,2383515-7-340-316
Net Cash Flow 115260-160-136-67322-1811,594-1,7892,316745
Free Cash Flow 3336011750530377270145899962917
CFO/OP 67%102%67%58%99%70%79%67%103%99%93%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash FlowN/A33.00360.00117.0050.00530.00377.00270.00145.00899.00962.00917.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 6262951031079083718987103101
Inventory Days 229283248271283388250312205421253265
Days Payable 7458601361611908297801285681
Cash Conversion Cycle 217288283239229289251286214381299284
Working Capital Days 100141155154185191161169168241224249
ROCE %39%22%28%30%22%27%30%28%25%15%17%16%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 57.86%57.86%57.86%51.83%51.83%51.83%51.83%51.83%51.83%51.83%51.83%51.77%
FIIs 4.91%4.05%3.59%6.88%4.48%5.04%6.90%7.39%7.90%7.58%7.29%8.74%
DIIs 22.45%24.17%25.23%32.83%35.37%34.80%33.27%32.86%32.63%32.99%33.36%30.44%
Public 14.78%13.93%13.32%8.46%8.33%8.33%8.00%7.93%7.63%7.62%7.52%9.06%
No. of Shareholders 1,61,6271,36,0211,22,3751,22,6651,22,3581,21,0751,13,7881,10,67197,15194,57891,5001,08,266
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Mid Cap Fund 6,111,753 1.22 1128.65,860,1792026-02-23 02:59:314.29%
SBI Large & Midcap Fund 3,170,000 1.56 585.372,000,0002025-12-08 00:33:5958.5%
Mirae Asset Large & Midcap Fund 3,110,648 1.36 574.413,075,9982026-01-25 03:15:351.13%
ICICI Prudential India Opportunities Fund 3,012,666 1.58 556.322,767,5172026-02-23 01:21:598.86%
Nippon India Growth Mid Cap Fund 2,800,000 1.24 517.05N/AN/AN/A
Mirae Asset ELSS Tax Saver Fund 2,384,231 1.69 440.272,283,9272026-02-23 02:59:314.39%
Mirae Asset Large Cap Fund 2,012,542 0.92 371.642,105,8932026-02-23 01:16:54-4.43%
Nippon India Small Cap Fund 1,780,371 0.5 328.761,696,9332025-12-08 00:33:594.92%
Mirae Asset Midcap Fund 1,676,184 1.75 309.52N/AN/AN/A
Nippon India Multi Cap Fund 1,466,415 0.55 270.791,416,4372025-12-08 00:33:593.53%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 42.4046.9047.4473.8163.07
Diluted EPS (Rs.) 42.4046.9047.4373.8162.99
Cash EPS (Rs.) 65.3367.8256.3380.4666.98
Book Value[Excl.RevalReserv]/Share (Rs.) 555.40529.65483.23435.64360.86
Book Value[Incl.RevalReserv]/Share (Rs.) 555.40529.65483.23435.64360.86
Revenue From Operations / Share (Rs.) 340.89343.92220.07267.85211.68
PBDIT / Share (Rs.) 89.9891.2776.82105.5487.84
PBIT / Share (Rs.) 67.0570.3567.9198.8381.80
PBT / Share (Rs.) 64.5068.7664.0398.5181.59
Net Profit / Share (Rs.) 42.4046.9047.4273.7560.94
NP After MI And SOA / Share (Rs.) 42.4046.9047.4273.7560.94
PBDIT Margin (%) 26.3926.5334.9039.4041.49
PBIT Margin (%) 19.6620.4530.8536.8938.64
PBT Margin (%) 18.9219.9929.0936.7738.54
Net Profit Margin (%) 12.4313.6321.5427.5328.79
NP After MI And SOA Margin (%) 12.4313.6321.5427.5328.79
Return on Networth / Equity (%) 7.638.859.8116.9216.88
Return on Capital Employeed (%) 11.4312.5013.8922.3922.36
Return On Assets (%) 6.227.248.8915.4615.34
Long Term Debt / Equity (X) 0.010.010.000.000.00
Total Debt / Equity (X) 0.020.030.000.000.00
Asset Turnover Ratio (%) 0.510.580.430.610.65
Current Ratio (X) 4.334.049.4610.0510.00
Quick Ratio (X) 3.262.856.808.027.51
Inventory Turnover Ratio (X) 3.361.251.101.661.72
Dividend Payout Ratio (NP) (%) 47.170.000.000.000.00
Dividend Payout Ratio (CP) (%) 30.610.000.000.000.00
Earning Retention Ratio (%) 52.830.000.000.000.00
Cash Earning Retention Ratio (%) 69.390.000.000.000.00
Interest Coverage Ratio (X) 35.3057.38169.90330.81421.28
Interest Coverage Ratio (Post Tax) (X) 17.6330.48113.46232.15293.28
Enterprise Value (Cr.) 23946.0928818.2817126.9950622.6337532.51
EV / Net Operating Revenue (X) 4.265.094.7311.5010.84
EV / EBITDA (X) 16.1519.1713.5429.1926.12
MarketCap / Net Operating Revenue (X) 4.675.365.7612.2111.71
Retention Ratios (%) 52.820.000.000.000.00
Price / BV (X) 2.873.482.637.506.87
Price / Net Operating Revenue (X) 4.675.365.7612.2111.71
EarningsYield 0.020.020.030.020.02
Advertisements
Explore Industry-wise Company financial data